麥迪衞康(02159.HK)香港公開發售獲168.75倍認購 預計1月19日掛牌上市
格隆匯 1 月 18日丨麥迪衞康(02159.HK)發佈公吿,公司全球發售5000萬股股份,其中香港發售股份2500萬股,國際發售股份2500萬股,另有15%超額配股權;發售價已釐定為每股發售股份3.00港元,每手買賣單位800股;光銀國際為獨家保薦人,預期股份將於2021年1月19日於聯交所主板掛牌上市。
國際發售初步提呈發售的發售股份已獲輕微超額認購,相當於國際發售初步可供認購的發售股份總數約1.13倍。根據香港公開發售初步提呈發售的香港發售股份獲大幅超額認購。公司合共接獲92,145份有效申請,認購合共8.438億股香港發售股份,相當於香港公開發售初步可供認購的香港發售股份總數約168.75倍。
按每股發售股份發售價3.00港元計算(假設並無超額配股權獲行使),公司將收取的全球發售所得款項淨額估計約為8930萬港元。公司擬將該等所得款項淨額約58%用於拓展集團的客户羣、疾病覆蓋範圍及患者羣;約25%將用於通過開發互聯網醫院服務補充集團的服務能力;約12%將用於運營資金及一般企業用途;及約5%將用於進一步擴充集團的CRO服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.